MENU
EMR
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

EMR stock forecast, quote, news & analysis

Founded in 1890 as the first manufacturer of electric fans in North America, Emerson Electric has become a leading industrial automation player through the acquisition of established brands... Show more

EMR
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
Aug 03, 2026

Emerson Electric (EMR) Stock Analysis: Rallying Into Q3 Earnings as Project Backlog Hits $8.2 Billion

Key Takeaways

  • Emerson Electric shares gained approximately 7.7% over the last 30 days, recovering from mid-July lows near $134 to close at $149.82 on July 31, 2026.
  • JPMorgan upgraded EMR to Overweight from Neutral on July 17, citing a $8.2 billion project backlog, up 9% year-over-year, and strengthening momentum in power, LNG, semiconductors, and aerospace & defense verticals.
  • The company is scheduled to report fiscal Q3 2026 earnings on August 4, with consensus estimates calling for EPS of $1.68 on revenue of $4.79 billion.
  • Wall Street maintains a Moderate Buy consensus rating with an average price target of approximately $163, implying roughly 9% upside from recent levels.
  • Emerson's deepening push into AI-driven industrial software and the completed Copeland divestiture to Blackstone continue reshaping its portfolio toward higher-growth automation markets.

Current Market Snapshot

Emerson Electric (EMR) enters August 2026 with renewed upward momentum after a volatile stretch earlier in the summer. The stock touched an intraday low of $134.20 on July 8 before staging a steady recovery, punctuated by a 3.9% surge on July 23 following the JPMorgan upgrade. Broader industrial sector sentiment has improved as rig count forecasts and refinery capital expenditure projections tick higher, and Emerson's heavy exposure to long-cycle automation projects provides a degree of insulation against shorter-term macro uncertainty. With institutional ownership sitting at approximately 74.3% of outstanding shares and several major holders—including Norges Bank, Vanguard, and State Street—adding to positions in recent quarters, institutional conviction in the automation thesis remains evident.

Emerson Electric (EMR) Business Overview and Competitive Position

Emerson Electric Co., headquartered in St. Louis, Missouri, is a global technology and engineering leader specializing in automation solutions for industrial, commercial, and residential markets. The company operates through two principal platforms: Automation Solutions, which delivers process automation systems, measurement and analytical instrumentation, valves and actuators, control software, and aftermarket services; and Commercial & Residential Solutions, which provides climate control products, tools, and storage solutions. Emerson has undergone a significant portfolio transformation, most notably completing the sale of a majority stake in its Climate Technologies business—now operating independently as Copeland under Blackstone's control—in a deal valued at $14 billion that generated approximately $9.7 billion in pre-tax cash proceeds. This repositioning allows Emerson to concentrate on high-growth automation end markets including power generation, LNG, life sciences, semiconductors, and aerospace & defense. The March 2025 acquisition of the remaining AspenTech shares made the industrial software leader a wholly owned subsidiary, further cementing Emerson's software-defined automation strategy.

Recent Developments Driving EMR

The most consequential catalyst over the past 30 days was JPMorgan's July 17 upgrade to Overweight with a $157 price target. The firm highlighted Emerson's $8.2 billion backlog—up 9% year-over-year—and the phasing of large, long-cycle projects as key drivers for the second half of fiscal 2026. JPMorgan also pointed to upside potential from Middle East rehabilitation work not yet reflected in company guidance, alongside improving flows through the Persian Gulf and an upward revision in rig count and refiner capex forecasts. Earlier in the quarter, Bernstein initiated coverage with an Outperform rating and a $175 target (later adjusted to $169), while RBC raised its target to $169. On the product front, Emerson launched two new refinery optimization tools—Crude Schedule Optimization and Multi-Blend Optimization—under the Aspen Unified Scheduling platform, and announced a partnership with SiMa.ai to embed advanced AI capabilities into industrial PCs for real-time, cloud-independent data analysis. The company also enhanced its AspenTech Inmation OT Data Fabric to support edge-to-cloud data management. Emerson's Q2 2026 results, reported May 5, showed adjusted EPS of $1.54 slightly ahead of consensus, with growth verticals surging 22% and software annual contract value reaching $1.64 billion. Full-year guidance was updated to $6.45–$6.55 adjusted EPS with approximately $2.2 billion planned for shareholder returns through dividends and buybacks.

Trending AI Robots

For traders seeking data-driven approaches to navigating stocks like Emerson Electric, Tickeron's Trending AI Robots page offers a curated view of the platform's top-performing algorithmic trading bots. Tickeron hosts hundreds of AI-powered trading bots that actively trade thousands of tickers across diverse strategies, timeframes, and risk profiles. The Trending AI Robots section filters this extensive universe to spotlight only the most relevant and highest-performing bots, making it easier for users to identify strategies aligned with current market conditions. Whether focused on short-term swing trades, longer-term trend following, or pattern recognition, each bot is tracked with transparent performance metrics. Exploring the Trending AI Robots page can help investors discover automated strategies that complement their own research on stocks like EMR.

2026 Outlook and What Investors Should Watch

Emerson's immediate focus is the August 4 Q3 earnings report, where investors will scrutinize execution across the Intelligent Devices and Software & Systems segments. Consensus forecasts point to EPS of $1.68 on approximately $4.79 billion in revenue, with particular attention on software ACV growth, backlog conversion rates, and any adjustments to full-year guidance in light of the ongoing Middle East conflict—which management previously modeled as a roughly one-percentage-point headwind. Beyond earnings, key themes for the remainder of 2026 include the trajectory of the $11.2 billion project funnel, progress in AI-enabled industrial automation deployments, and the pace of capital returns under Emerson's $2.2 billion shareholder return plan. Macroeconomic factors—including interest rate policy, industrial production trends in China and Europe, and energy sector capital spending—will continue to influence demand across Emerson's end markets. Analysts also expect the company's portfolio reshaping initiatives and software-focused acquisitions to begin contributing more meaningfully to margin expansion as fiscal 2027 approaches.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

A.I.Advisor
a Summary for EMR with price predictions
Aug 07, 2026

EMR in upward trend: price rose above 50-day moving average on July 23, 2026

EMR moved above its 50-day moving average on July 23, 2026 date and that indicates a change from a downward trend to an upward trend. In of 44 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 21, 2026. You may want to consider a long position or call options on EMR as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EMR just turned positive on July 22, 2026. Looking at past instances where EMR's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for EMR crossed bullishly above the 50-day moving average on July 27, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EMR advanced for three days, in of 334 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for EMR moved out of overbought territory on August 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

EMR broke above its upper Bollinger Band on July 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for EMR entered a downward trend on July 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. EMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.331) is normal, around the industry mean (6.054). P/E Ratio (34.630) is within average values for comparable stocks, (77.595). Projected Growth (PEG Ratio) (1.837) is also within normal values, averaging (2.237). Dividend Yield (0.014) settles around the average of (0.018) among similar stocks. P/S Ratio (4.785) is also within normal values, averaging (141.087).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Dividends

EMR is expected to pay dividends on September 10, 2026

Emerson Electric Co EMR Stock Dividends
A dividend of $0.56 per share will be paid with a record date of September 10, 2026, and an ex-dividend date of August 14, 2026. The last dividend of $0.56 was paid on June 10. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Illinois Tool Works (NYSE:ITW), Ingersoll Rand (NYSE:IR), Generac Holdings (NYSE:GNRC).

Industry description

The industry makes and maintains machines for consumers, the industry, and most other companies. While it has traditionally been categorized as heavy industry, some smaller companies are also branching into the light category. The industry is pivotal in providing the equipment for production in businesses like agriculture, mining, industry and construction, gas, electricity and water utilities. It also supplies supporting equipment for almost all sectors of the economy, such as equipment for heating, and air conditioning of buildings. Illinois Tool Works Inc., Parker-Hannifin Corporation and Rockwell Automation Inc are some of the major U.S. companies operating in this industry.

Market Cap

The average market capitalization across the Industrial Machinery Industry is 17.05B. The market cap for tickers in the group ranges from 1.55K to 263.76B. GEV holds the highest valuation in this group at 263.76B. The lowest valued company is XEBEF at 1.55K.

High and low price notable news

The average weekly price growth across all stocks in the Industrial Machinery Industry was 1%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was -5%. PSIX experienced the highest price growth at 48%, while LBGJ experienced the biggest fall at -100%.

Volume

The average weekly volume growth across all stocks in the Industrial Machinery Industry was -21%. For the same stocks of the Industry, the average monthly volume growth was 21% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 55
Price Growth Rating: 53
SMR Rating: 72
Profit Risk Rating: 72
Seasonality Score: -35 (-100 ... +100)
View a ticker or compare two or three
EMR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of process controls systems, valves and analytical instruments

Industry IndustrialMachinery

Profile
Details
Industry
Electrical Products
Address
8000 West Florissant Avenue
Phone
+1 314 553-2000
Employees
67000
Web
https://www.emerson.com
Emerson Electric (EMR) Stock Analysis: Rallying Into Q3 Earnings as Project Backlog Hits $8.2 Billion